115 related articles for article (PubMed ID: 21257797)
1. Standardized visual predictive check versus visual predictive check for model evaluation.
Wang DD; Zhang S
J Clin Pharmacol; 2012 Jan; 52(1):39-54. PubMed ID: 21257797
[TBL] [Abstract][Full Text] [Related]
2. [Comparison study of model evaluation methods: normalized prediction distribution errors vs. visual predictive check].
Ren YP; Deng CH; Wang XP; Zhou TY; Lu W
Yao Xue Xue Bao; 2011 Sep; 46(9):1123-31. PubMed ID: 22121786
[TBL] [Abstract][Full Text] [Related]
3. Prediction discrepancies for the evaluation of nonlinear mixed-effects models.
Mentré F; Escolano S
J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):345-67. PubMed ID: 16284919
[TBL] [Abstract][Full Text] [Related]
4. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.
Bergstrand M; Hooker AC; Wallin JE; Karlsson MO
AAPS J; 2011 Jun; 13(2):143-51. PubMed ID: 21302010
[TBL] [Abstract][Full Text] [Related]
5. A new equivalence based metric for predictive check to qualify mixed-effects models.
Jadhav PR; Gobburu JV
AAPS J; 2005 Oct; 7(3):E523-31. PubMed ID: 16353930
[TBL] [Abstract][Full Text] [Related]
6. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
Comets E; Brendel K; Mentré F
Comput Methods Programs Biomed; 2008 May; 90(2):154-66. PubMed ID: 18215437
[TBL] [Abstract][Full Text] [Related]
7. Visual Predictive Check in Models with Time-Varying Input Function.
Largajolli A; Bertoldo A; Campioni M; Cobelli C
AAPS J; 2015 Nov; 17(6):1455-63. PubMed ID: 26265094
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of different tests based on observations for external model evaluation of population analyses.
Brendel K; Comets E; Laffont C; Mentré F
J Pharmacokinet Pharmacodyn; 2010 Feb; 37(1):49-65. PubMed ID: 20033477
[TBL] [Abstract][Full Text] [Related]
9. Extensions to the visual predictive check to facilitate model performance evaluation.
Post TM; Freijer JI; Ploeger BA; Danhof M
J Pharmacokinet Pharmacodyn; 2008 Apr; 35(2):185-202. PubMed ID: 18197467
[TBL] [Abstract][Full Text] [Related]
10. Comparison of robust criteria for D-optimal designs.
Foo LK; McGree J; Eccleston J; Duffull S
J Biopharm Stat; 2012; 22(6):1193-205. PubMed ID: 23075017
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics III: design, analysis, and application of population pharmacokinetic Studies.
Ette EI; Williams PJ; Lane JR
Ann Pharmacother; 2004 Dec; 38(12):2136-44. PubMed ID: 15507495
[TBL] [Abstract][Full Text] [Related]
12. Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide.
Brendel K; Comets E; Laffont C; Laveille C; Mentré F
Pharm Res; 2006 Sep; 23(9):2036-49. PubMed ID: 16906454
[TBL] [Abstract][Full Text] [Related]
13. Application of a hazard-based visual predictive check to evaluate parametric hazard models.
Huh Y; Hutmacher MM
J Pharmacokinet Pharmacodyn; 2016 Feb; 43(1):57-71. PubMed ID: 26563504
[TBL] [Abstract][Full Text] [Related]
14. Bayesian population modeling of phase I dose escalation studies: Gaussian process versus parametric approaches.
Russu A; Poggesi I; Gomeni R; De Nicolao G
IEEE Trans Biomed Eng; 2011 Nov; 58(11):3156-64. PubMed ID: 21846598
[TBL] [Abstract][Full Text] [Related]
15. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
16. Estimation of prediction error for survival models.
Lawless JF; Yuan Y
Stat Med; 2010 Jan; 29(2):262-74. PubMed ID: 19882678
[TBL] [Abstract][Full Text] [Related]
17. Marginal estimation for multi-stage models: waiting time distributions and competing risks analyses.
Satten GA; Datta S
Stat Med; 2002 Jan; 21(1):3-19. PubMed ID: 11782047
[TBL] [Abstract][Full Text] [Related]
18. A point estimator for the time course of drug release.
Koehne-Voss S; Pigeot I
Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
[TBL] [Abstract][Full Text] [Related]
19. Inverse probability of censoring weighting for visual predictive checks of time-to-event models with time-varying covariates.
Bartels C; Dumortier T
Pharm Stat; 2021 Nov; 20(6):1051-1060. PubMed ID: 33855777
[TBL] [Abstract][Full Text] [Related]
20. Methods of robust design of nonlinear models with an application to pharmacokinetics.
Foo LK; Duffull S
J Biopharm Stat; 2010 Jul; 20(4):886-902. PubMed ID: 20496212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
